3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
17
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
5
Leukemia
5
Hemangioma
5
Lymphoma, Large-Cell, Anaplastic
4
Prostatic Neoplasms
3
Neoplasms
3
Lymphoma, B-Cell
3
Immunoblastic Lymphadenopathy
3
Neurotoxicity Syndromes
2
Neoplasm, Residual
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Esophageal Stenosis
2
Enteropathy-Associated T-Cell Lymphoma
2
Vomiting
1
Thymoma
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Polycystic Ovary Syndrome
1
Philadelphia Chromosome
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Nausea
1
Interventions
Endoscopy
12
Endoscopy, Digestive System
9
Endoscopic Mucosal Resection
8
Biopsy
7
Specimen Handling
5
Gastroscopy
5
Omeprazole
4
Radiofrequency Ablation
3
Esomeprazole
3
Breath Tests
3
Proton Pump Inhibitors
2
Photochemotherapy
2
Narrow Band Imaging
2
Microscopy, Confocal
2
Endoscopes
2
Diagnostic Imaging
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
plecanatide
1
omeprazole, sodium bicarbonate drug combination
1
linaclotide
1
gluconic acid
1
chlorhexidine gluconate
1
candesartan cilexetil
1
candesartan
1
YF 476
1
Tomography, Optical Coherence
1
Tamoxifen
1
Surveys and Questionnaires
1
Sunitinib
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Barrett Esophagus
×
Prednisolone
×
Clear all
NCT02004782
2025-03-27
BERST
Western Sydney Local Health District
Phase 4
Withdrawn